Arrowhead approach for malignancies in the lower hemisphere of the breast

For decades, breast conservation treatment (BCT) was considered to provide similar survival outcomes compared to mastectomy. Recent data, however, appears to suggest differently. Although it is yet to be widely accepted and incorporated into guidelines for the contemporary treatment of breast cancer, there has been accumulating evidence over the last decade suggesting that BCT results in higher survival outcomes and better local control than mastectomy (1-3). In anticipation of the possible shift in treatment philosophy in line with these data and its potential impact, it would be logical to devise methods to optimise BCT rates